Vaccines are considered to be one of the biggest public health achievements of the past century. Vaccines act by initiating the innate immune response when activating antigen presenting cells, inducing a protective response towards a pathogen. These agents may contain live attenuated, inactivated, or only parts of a pathogen.
Corning provides diverse single-use products for upstream vaccine manufacturing needs reducing the cost and minimizing the labor per titer.
This webinar provides background information about the main forms of vaccine design, R&D, and manufacturing workflows, data generated in Corning’s application labs and vaccine considerations for COVID-19.